Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Biostatistics: Overview01:20

Biostatistics: Overview

379
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
379
Data: Types and Distribution01:19

Data: Types and Distribution

851
In biostatistics, data are the observations collected for analysis. There are two main types: parametric and non-parametric. Parametric data, which include continuous (e.g., weight) and discrete numerical data (e.g., number of tablets), assume a particular distribution pattern, often the normal distribution. Non-parametric data do not adhere to a specific distribution and typically comprise nominal (e.g., gender) and ordinal categorical data (e.g., pain scale ratings).
Distributions in...
851
Discharge Summary Forms01:31

Discharge Summary Forms

824
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
824
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

987
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
987
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017-2023.

National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System·2026
Same author

Drug Overdose Deaths in the United States, 2023-2024.

NCHS data brief·2026
Same author

Unintentional Fall Deaths in Adults Age 65 and Older: United States, 2023.

NCHS data brief·2025
Same author

Changes in Suicide Rates in the United States From 2022 to 2023.

NCHS data brief·2025
Same author

Trends in Births and Deaths: United States, 2010-2023.

National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System·2025
Same author

Health E-Stats.

NCHS data brief·2025
Same journal

Mental Health Treatment Among Adults: United States, 2024.

NCHS data brief·2026
Same journal

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

NCHS data brief·2026
Same journal

Dietary Supplement Use: United States, August 2021-August 2023.

NCHS data brief·2026
Same journal

Urgent Care Center and Retail Health Clinic Use: United States, 2024.

NCHS data brief·2026
Same journal

Birth Expectations of Women Ages 20-49: United States, 2022-2023.

NCHS data brief·2026
Same journal

Short Sleep Duration and Sleep Difficulties Among Adults: United States, 2024.

NCHS data brief·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K

Drug Overdose Deaths in the United States, 2003–2023

Matthew F Garnett, Arialdi M Miniño

    NCHS Data Brief
    |July 7, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Overall drug overdose deaths declined slightly in 2023, but stimulant-involved overdose deaths, particularly cocaine, saw an increase. Rates also rose for older adults and some demographic groups, highlighting persistent challenges in the opioid and stimulant crisis.

    More Related Videos

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
    09:33

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

    Published on: December 23, 2022

    2.4K
    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
    04:04

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

    Published on: July 11, 2025

    306

    Related Experiment Videos

    Last Updated: Sep 16, 2025

    A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
    07:50

    A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

    Published on: September 20, 2018

    16.0K
    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
    09:33

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

    Published on: December 23, 2022

    2.4K
    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
    04:04

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

    Published on: July 11, 2025

    306

    Area of Science:

    • Public Health
    • Epidemiology
    • Toxicology

    Background:

    • Drug overdose deaths remain a significant public health concern in the United States.
    • Understanding trends in overdose deaths by drug type and demographic group is crucial for targeted interventions.

    Purpose of the Study:

    • To analyze recent trends in drug overdose death rates from 2022 to 2023.
    • To examine changes in overdose deaths by demographic characteristics and specific drug classes, including opioids and stimulants.

    Main Methods:

    • Utilized National Vital Statistics System mortality data from 2003-2023.
    • Defined drug poisoning deaths using International Classification of Diseases, 10th Revision (ICD-10) codes.
    • Calculated age-adjusted death rates and assessed trends using Joinpoint Regression Program.

    Main Results:

    • The overall age-adjusted drug overdose death rate decreased from 32.6 to 31.3 per 100,000 population between 2022 and 2023.
    • Rates declined for younger age groups (15-54) but increased for adults 55 and older.
    • Deaths involving synthetic opioids, heroin, and natural/semisynthetic opioids decreased, while cocaine and psychostimulant-involved deaths increased.

    Conclusions:

    • While overall overdose death rates show a slight decline, the increase in stimulant-related deaths and rising rates in older adults signal evolving challenges.
    • Continued monitoring and tailored public health strategies are necessary to address the complex and changing landscape of the drug overdose epidemic.